{"id":1934,"date":"2016-07-09T04:23:11","date_gmt":"2016-07-09T04:23:11","guid":{"rendered":"http:\/\/zestmag.com\/online\/?p=1934"},"modified":"2016-07-09T04:23:11","modified_gmt":"2016-07-09T04:23:11","slug":"galderma-announces-fda-approval-of-differin-for-otc-acne-use","status":"publish","type":"post","link":"https:\/\/zestmag.com\/online\/galderma-announces-fda-approval-of-differin-for-otc-acne-use\/","title":{"rendered":"Galderma announces FDA approval of Differin for OTC acne use"},"content":{"rendered":"
\n
\n
\n
\n

Galderma announced that its US affiliate, Galderma Laboratories, received approval from the US Food and Drug Administration (FDA) for Differin\u00a0Gel (adapalene gel 0.1%) as an over-the-counter (OTC) treatment for acne. This approval makes Differin\u00a0Gel the first and only OTC acne product containing a full prescription-strength retinoid.\u00a0 It also marks the first new, FDA-approved active ingredient to be introduced to the OTC acne category in over three decades.<\/strong><\/p>\n

\"Differin\"<\/a><\/p>\n

“We believe bringing Differin\u00a0Gel over-the-counter will be a game-changer for consumers and for the acne category,” said Miles Harrison<\/span>, president and GM of Galderma Laboratories. “We’re excited to deliver this new level of efficacy without a prescription to consumers, and to bring the first new active ingredient to the category in over 30 years. As the research and development leader of medically proven dermatologic solutions, Galderma is proud to announce this innovation will be available for people with skin health needs.”<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n

\n
\n
\n

Acne is the most common skin condition in the US alone<\/span>, affecting up to 60 million teens and adults annually, however, only one-third seek out the help of a healthcare provider to address these issues2<\/sup>. In fact, 45 percent of adults are not satisfied with their current products, with nearly half of people using three or more acne products. With a growing trend among consumers to self-treat, many turn to the skincare aisle at their local drugstore. Until now, there have been only two active ingredients on the over-the-counter market*, leaving many people dissatisfied and searching for better options. With the Rx to OTC switch of Differin\u00a0Gel, millions of people will have easier access to a full prescription-strength product containing a retinoid.<\/p>\n

“This landmark approval was years in the making at Galderma and demonstrates our ongoing commitment to individuals with dermatologic concerns such as acne,” said Philip Brown<\/span>, MD, JD, SVP, Medical and Regulatory Affairs, Galderma Laboratories. “Galderma will continue to partner with healthcare professionals and invest in Rx, OTC and Aesthetic & Corrective medical innovations to enhance skin health.”<\/p>\n

Differin\u00a0Gel containing 0.1% adapalene is specially formulated for efficacy and tolerability. It is a full prescription-strength, once-a-day topical containing a retinoid, which is clinically proven to treat current and future breakouts.\u00a0 An innovation from Galderma R&D, the dermatologist-developed and tested Differin\u00a0Gel contains adapalene, a safe and effective retinoid, which doctors have prescribed to over 40 million people globally for more than 20 years.\u00a0 According to the American Academy of Dermatology’s therapeutic treatment guidelines, topical retinoids are recommended as first-line therapy for all acne cases.<\/p>\n

Differin\u00a0Gel is clear, fragrance-free, oil-free and alcohol-free. Differin\u00ae<\/sup> Gel is applied once daily, directly to the full-face or other affected areas. It is approved for use by people 12 years and older with acne.<\/p>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

This approval makes Differin Gel the first and only OTC acne product containing a full prescription-strength retinoid. It also marks the first new, FDA-approved active ingredient to be introduced to the OTC acne category in over three decades.<\/p>\n","protected":false},"author":3,"featured_media":1935,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,16],"tags":[1131,1132,1130,1129,19,603,20],"class_list":["post-1934","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsmakers","category-product-showcase","tag-acne","tag-adapalen","tag-differin","tag-differin-gel","tag-health","tag-skincare","tag-wellness"],"_links":{"self":[{"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/posts\/1934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/comments?post=1934"}],"version-history":[{"count":1,"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/posts\/1934\/revisions"}],"predecessor-version":[{"id":1936,"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/posts\/1934\/revisions\/1936"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/media\/1935"}],"wp:attachment":[{"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/media?parent=1934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/categories?post=1934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/tags?post=1934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}